Whitehawk Therapeutics, Inc. (WHWK): Nasdaq/NYSE listing notice — AADI Bioscience regains compliance with Nasdaq audit committee independence rule

Whitehawk Therapeutics, Inc.

Non-compliance resulted from Dr. Karin Hehenberger not qualifying as independent per Nasdaq Listing Rule 5605(c)(2)(A).
Board removed Hehenberger from Audit Committee and appointed Caley Castelein, M.D., who meets independence requirements.
Audit Committee now consists of Emma Reeve (chair), Richard Maroun, and Caley Castelein; company believes compliance restored.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Whitehawk Therapeutics, Inc. received a nasdaq compliance regained notice regarding audit committee (rules 5605(c)(2)(A)).

Exchange: nasdaq
Notice: compliance regained
Deficiency: audit committee
Rules: 5605(c)(2)(A)

Exact text from the filing

November 23, 2022, Aadi Bioscience, Inc. (the “Company”) notified The Nasdaq Stock Market LLC (“Nasdaq”) of the Company’s non-compliance with Nasdaq’s audit committee composition requirements set forth in Nasdaq Listing Rule 5605(c)(2)(A), which require, among other things, an audit committee to consist of at least three members, each of whom is independent. The non-compliance was a result of Karin Hehenberger, M.D., Ph.D., a member of the Audit Committee (the “Audit Committee”) of the board of directors of the Company (the “Board”), not qualifying as independent pursuant to Nasdaq Listing Rul

View on SEC.gov

6 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Whitehawk Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-292703

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.